Suggestions
Sylvia Stockler
Professor of Pediatrics at University of British Columbia
Dr. Sylvia Stockler, also known as Stoeckler or Stöckler-Ipsiroglu, is a highly accomplished professional with academic degrees in MD, PhD, and MBA.
Her clinical research focus revolves around rare diseases, inborn errors of metabolism, and orphan drugs, with the goal of enhancing current treatments and pioneering new therapies for rare inborn errors of metabolism.
Among her notable achievements are the introduction of expanded newborn screening for over 20 inborn errors of metabolism in the Austrian National Newborn Screening Programme from 1996 to 2004.
From 2012 to 2016, she spearheaded the Development & Dissemination of the Treatable Intellectual Disabilities (TIDE) Protocol, aimed at identifying treatable causes of intellectual disability in children and uncovering new causes of ID through NGS.
Since 2016, Dr. Stockler has been involved in the International Natural History Study for Morquio B Disease and GLB1-related conditions leading to skeletal dysostosis.
With a portfolio of over 200 peer-reviewed articles and book chapters, she is an expert in Creatine deficiency disorders and GLB1-related disorders.
Dr. Stockler obtained her MBA from WU (Vienna University of Economics and Business), PhD from The University of Göttingen, and MD from Karl-Franzens-Universität Graz.
Currently, she serves as a Professor of Paediatrics and Head of the Division of Biochemical Genetics at BC Children's Hospital, Vancouver, affiliated with the University of British Columbia (UBC).
Her previous roles include being a Professor of Paediatrics at UBC, Associate Professor of Paediatrics and Director of the National Austrian Newborn Screening Programme at the Medical University of Vienna, as well as Assistant Professor positions at Georg-August-Universität Göttingen and Karl-Franzens University of Graz.
